👇
“Our results showed upregulation of chemotactic factors, including CCL4, CCL8, and CCL11, that all shared CCR5 as their receptor, as a common derangement observed in both diseases; RA and COVID-19.” https://t.co/SfmnU2OT9T
RT @CindyGlasgow: Can hydroxychloroquine be useful for #MEcfs? "This might be achieved through the ability of HCQ to upregulate specific im…
C-C chemokine receptor type 5 links #COVID19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis https://t.co/WSm279uiCF https://t.co/l5XHrhyxFL
C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis. by Hachim MY, Hachim IY, Naeem KB, Hannawi H, Al Salmi I, Hannawi S https://t.co/0wX7VQu5oX
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
@brucep13 Just more confirmation . https://t.co/iG9ZlWdTy8
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
Can hydroxychloroquine be useful for #MEcfs? "This might be achieved through the ability of HCQ to upregulate specific immune cell populations like activated natural killer (NK) cells, which were found to be significantly reduced in COVID-19 infection." h
@drbeen_medical More questions about NKC function! Can hydroxychloroquine enhance natural killer cell function and if so, how? Would low dose hcq be useful to increase NKC function? https://t.co/2sY0Vs701m
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
In COVID-19 patients, disruption of the CCL5-CCR5 axis through CCR5 blocking antibody leronlimab was shown to reduce plasma IL-6, and SARS-CoV-2 plasma viremia [34]. https://t.co/3j3v96vdD0
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
https://t.co/Wz5w8eKNuD this. @G23Mld
RT @lane_bryanalane: New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykF…
New paper out on CCR5! Covid, RA and Hydroxychloroquine. $cydy #leronlimab @CytoDyn @YoDoctorYo https://t.co/3cJiykFAf5